99m Tc-PSMA Scintigraphy of Subcutaneous Angiolipoma.
We present a case of a 69-year-old man diagnosed with prostate adenocarcinoma, who underwent 99m Tc-PSMA scintigraphy as part of his initial staging workup.
APA
Saber Tanha A, Rafiei Z, et al. (2025). 99m Tc-PSMA Scintigraphy of Subcutaneous Angiolipoma.. Clinical nuclear medicine, 50(7), e428-e429. https://doi.org/10.1097/RLU.0000000000005741
MLA
Saber Tanha A, et al.. "99m Tc-PSMA Scintigraphy of Subcutaneous Angiolipoma.." Clinical nuclear medicine, vol. 50, no. 7, 2025, pp. e428-e429.
PMID
39992809
Abstract
We present a case of a 69-year-old man diagnosed with prostate adenocarcinoma, who underwent 99m Tc-PSMA scintigraphy as part of his initial staging workup. The scan revealed a focal uptake in the posterior abdominal wall, corresponding to a subcutaneous soft tissue lesion. Further evaluation using SPECT/CT imaging localized the lesion, which was subsequently excised and histopathologically diagnosed as an angiolipoma. This case represents the first reported instance of PSMA-based detection of angiolipoma as a false-positive finding using 99m Tc-PSMA scintigraphy.
MeSH Terms
Humans; Male; Aged; Angiolipoma; Glutamate Carboxypeptidase II; Subcutaneous Tissue; Radionuclide Imaging; Antigens, Surface; Single Photon Emission Computed Tomography Computed Tomography
같은 제1저자의 인용 많은 논문 (5)
- FAPI Uptake in Avascular Necrosis of the Talus.
- Experience With 177Lu-FAPI-2286 Therapy as the Last Resort in a Patient With Metastatic Colon Cancer.
- Spondylodiscitis: A False-Positive Pitfall in 68 Ga-PSMA Scintigraphy.
- FAPI-Based Theranostics in Medullary Thyroid Cancer: A Viable Alternative When Somatostatin Receptor-Based Theranostics Show Limited Efficacy-A Clinical Experience.
- Superior Diagnostic Performance of ⁶⁸Ga-FAPI PET/CT Compared With ⁶⁸Ga-DOTATATE PET/CT in Medullary Thyroid Carcinoma.